NZ577415A

Breathing apparatus attached to the face using a hook and loop fastener having one side adhered to the skin

Abstract

A patient interface system for delivering a flow of breathable gas to a patient (1) is disclosed. The system is attached to the patent (1) using a hook and loop fastener (2144, 2138), one side of which (2138) is adhered to the patent (1). This allows the system to be removed and reattached numerous times without the need of a strap or re-adhering the system.

NZ577415A, drawing sheet 1
Sheet 1 of 57

Term

2.7 yearsto projected expiry

Projected expiry 4 June 2029, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

55 claims: 32 independent, 23 dependent

  1. 1
    WHAT IS CLAIMED IS:1. A patient interface system for delivering a flow of breathable gas to a patient, comprising: a first component comprising adhesive and loop or hook material, wherein the adhesive is configured to adhere the first component to the face of the patient;and a patient interface structure configured to sealingly engage the patient’s airways, the patient interface structure including a second component comprising a hook or loop material configured to engage the corresponding loop or hookmaterial of the first strip to secure the patient interface structure in sealing engagement with the patient’s face, wherein the patient interface structure is adjustable by disengaging the second component and the first component from each other and reengaging the second component and the first component with each other while the first component remains adhered to the patient.
  2. 4
    A patient interface system according to 1, wherein the loop material is provided in zones on the second side of the first component.
  3. 5
    A patient interface system according to any one of claims 1-4, wherein the second component is mechanically secured to the patient interface structure.
  4. 6
    A patient interface system according to any one of claims 1-4, wherein the second component is adhesively secured to the patient interface structure.
  5. 7
    A patient interface system according to any one of claims 1-6, wherein the second component is secured to an exterior of the patient interface structure.
  6. 8
    A patient interface system according to any one of claims 1-6, wherein the second component is secured to an interior of the patient interface structure.
  7. 9
    A patient interface system according to any one of claims 1-8, further comprising a wire connected to the second component and configured to provide a nasal passages dilating force when the hook material and the loop material are engaged. Recived at IPONZ 2 Decemeber 2010
  8. 10
    A patient interface system according to any one of claims 1-8, further comprising at least one spring connected to the second component and configured to provide a nasal passages dilating force when the hook material and the loop material are engaged.
  9. 15
    A patient interface system according to any one of claims 1-14, wherein the adhesive comprises a zinc oxide based adhesive, a synthetic rubber, acrylic, silicone gel, and/or polyurethane.
  10. 16
    A patient interface system according to any one of claims 1-15, wherein the adhesive does not leave a residue on the patient’s face.
  11. 17
    A patient interface system according to any one of claims 1-16, wherein the adhesive and/or the patient interface structure is disposable.
  12. 18
    A patient interface system according to any one of claims 1-17, wherein the adhesive comprises an end of life indicator.
  13. 19
    A patient interface system according to any one of claims 1-18, further comprising an adhesive fitting guide provided on the adhesive and/or the patient interface structure.
  14. 21
    A patient interface system according to any one of claims 1-20, wherein the adhesive has an adhesion area of about 400 mm 2 - 900 mm 2 . Recived at IPONZ 2 Decemeber 2010
  15. 29
    A patient interface system according to any one of claims 1-28, wherein the adhesive is configured to support approximately 50g - 300g.
  16. 34
    A patient interface system according to any one of claims 1-33, wherein the adhesive is configured such that, at an angle of 150° to the patient’s face, a peel force required to remove the adhesive from the patient’s face is to be no more than about 1.5N/15mm without the adhesive attached to the patient interface structure or support.
  17. 35
    A patient interface system according to any one of claims 1-34, wherein the adhesive is configured to maintain the patient interface in sealing contact with the Recived at IPONZ 2 Decemeber 2010 patient’s nares when the flow of breathable gas to the patient interface is about 2 cm H 2 O - 20 cmH 2 0.
  18. 36
    A patient interface system according to any one of claims 1-34, wherein the adhesive is configured to maintain the patient interface in sealing contact with the patient’s nares when the flow of breathable gas to the patient interface is about 4 - 12 cm H 2 O.
  19. 38
    A patient interface system according to any one of claims 1-37, wherein the adhesive is configured not to be displaced by more than about 0.3 mm from an original position during use.
  20. 39
    A patient interface system according to any one of claims 1-38, wherein the adhesive is configured to maintain its characteristics up to about 45°C.
  21. 40
    A patient interface system according to any one of claims 1-39, wherein the adhesive is configured to maintain its characteristics over a range of relative humidity.
  22. 41
    A patient interface system according to any one of claims 1 -40, wherein the adhesive is not more than about 5 mm thick.
  23. 42
    A patient interface system according to any one of claims 1-41, wherein the adhesive is configured to remain adhered to the patient’s skin for at least about 4 hours.
  24. 45
    A patient interface system according to any one of claims 1-44, wherein the adhesive is biocompatible.
  25. 46
    A patient interface system according to any one of claims 1-45, wherein the adhesive is biodegradable.
  26. 47
    A patient interface system according to any one of claims 1-46, wherein the adhesive is clear. Recived at IPONZ 2 Decemeber 2010
  27. 48
    A patient interface system according to any one of claims 1-47, wherein the adhesive is skin toned.
  28. 49
    A patient interface system according to any one of claims 1-48, further comprising a non-adhesive strip configured to cover the adhesive.
  29. 51
    A patient interface system according to any one of claims 1-50, wherein the adhesive comprises at least one hole configured to allow venting.
  30. 52
    A patient interface system according to any one of claims 1-51, wherein the adhesive is configured to be sterilized.
  31. 53
    A patient interface system according to any one of claims 1-52, wherein the adhesive is configured to provide a warming effect.
  32. 54
    A patient interface system according to any one of claims 1-53, wherein the adhesive comprises a light switching adhesive.
Independent claims32